Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication

Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication

ABSTRACT INTRODUCTIONLife expectancy in patients with schizophrenia is 15–20 years less than the general population. A dominant cause of morbidity and mortality in these patients is cardiovascular disease. Adverse consequences of modifiable cardiovascular risk factors can be reduced by regular monit...

Full description

Bibliographic Details
Main Authors: Ross Lawrenson, Sophie Scarlet, Ruzaimah Mohammed, Kee Ping Lim, Shivam Deo, Abhijit Bhat, Muhammad Asim, Chunhuan Lao, Sally Carter, Joanna Ly, Lynne Chepulis, Rawiri Keenan
Format: Article
Language:English
Published: CSIRO Publishing 2020-01-01
Series:Journal of Primary Health Care
Online Access:https://www.publish.csiro.au/hc/pdf/HC19023

Internet

https://www.publish.csiro.au/hc/pdf/HC19023

Similar Items